# Evaluation of the Impact of Oral Ivermectin on Musca Sorbens Flies, Putative Vector of Trachoma

> **NCT07657143** · PHASE4 · NOT_YET_RECRUITING · sponsor: **London School of Hygiene and Tropical Medicine** · enrollment: 12 (estimated)

## Conditions studied

- Survival of Flies Developing in Faecal Samples

## Interventions

- **DRUG:** Ivermectin

## Key facts

- **NCT ID:** NCT07657143
- **Lead sponsor:** London School of Hygiene and Tropical Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07
- **Primary completion:** 2026-11
- **Final completion:** 2026-12
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2026-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07657143

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07657143, "Evaluation of the Impact of Oral Ivermectin on Musca Sorbens Flies, Putative Vector of Trachoma". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07657143. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*